During medical emergencies, when decisions must be made quickly, knowing how blood thinners are affecting a person’s ability ...

Lupin has received the Food and Drug Administration’s green light for rivaroxaban tablets, in 10 mg, 15 mg and 20 mg, which is the generic of Janssen’s Xarelto. This product will be ...

Rivaroxaban tablets, 2.5 mg, have a market value of roughly $447 million for the 12 months ending February 2025, per IQVIA. [Read more: Aurobindo obtains FDA OK for generic Keflet] ...

The estimated market size of all the strengths of Rivaroxaban tab USP, in the U.S., was $8.5 billion for the twelve months ended February 2025, according to IQVIA, the company said.

CHICAGO — In the RIVAWAR trial, patients hospitalized for a heart attack who were treated with rivaroxaban for left ventricular thrombus had comparable outcomes at 3 months to patients treated ...

FDA’s Center for Drug Evaluation and Research (CDER) Division of Drug Information said on March 10, 2025 that FDA has approved the first generics of rivaroxaban, in tablet form, to reduce risk of ...

The incidence rate of ischemic stroke was 1.21 events per 100 person-years with 150-mg abelacimab and 1.24 with 90-mg abelacimab as compared with 0.59 per 100 person-years with rivaroxaban (hazard ...

POCT specific to NOAC are currently unavailable, but influences of NOAC on established coagulation POCT have been reported. 6–10 Data based on artificially spiked blood samples from healthy volunteers ...

Abelacimab was compared with another standard-of-care anti-clotting medication rivaroxaban for occurrence of bleeding in a study of more than 1,200 people at moderate to high risk of stroke from ...

Compared with rivaroxaban, both doses of abelacimab greatly reduced risk for the primary endpoint of major or clinically relevant nonmajor bleeding at approximately 2 years (HR for abelacimab 90 ...

The COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) trial randomized 27 395 individuals with stable atherosclerotic vascular disease to receive the DPI with rivaroxaban ...